Role of the ALK Inhibitor AZD3463 in Sorafenib-Resistant Acute Myeloid Leukemia

Investigators evaluated whether  AZD3463 can induce apoptosis in a dose-dependent manner in a subset of AML patients.

Source: CancerNetwork - February 8, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news